Annual Total Liabilities
$3.75 M
-$1.06 M-22.14%
December 31, 2023
Summary
- As of February 7, 2025, CANF annual total liabilities is $3.75 million, with the most recent change of -$1.06 million (-22.14%) on December 31, 2023.
- During the last 3 years, CANF annual total liabilities has risen by +$297.00 thousand (+8.61%).
- CANF annual total liabilities is now -47.65% below its all-time high of $7.16 million, reached on December 31, 2015.
Performance
CANF Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$3.44 M
-$303.00 K-8.09%
June 30, 2024
Summary
- As of February 7, 2025, CANF quarterly total liabilities is $3.44 million, with the most recent change of -$303.00 thousand (-8.09%) on June 30, 2024.
- Over the past year, CANF quarterly total liabilities has dropped by -$715.00 thousand (-17.20%).
- CANF quarterly total liabilities is now -57.59% below its all-time high of $8.12 million, reached on September 30, 2015.
Performance
CANF Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CANF Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.1% | -17.2% |
| 3 y3 years | +8.6% | -39.9% |
| 5 y5 years | -24.1% | -34.1% |
CANF Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.2% | at low | -41.4% | at low |
| 5 y | 5-year | -36.2% | +8.6% | -41.4% | at low |
| alltime | all time | -47.6% | +132.5% | -57.6% | +208.1% |
Can-Fite BioPharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $3.44 M(-8.1%) |
| Dec 2023 | $3.75 M(-22.1%) | $3.75 M(-4.8%) |
| Sep 2023 | - | $3.93 M(-5.4%) |
| Jun 2023 | - | $4.16 M(-16.8%) |
| Mar 2023 | - | $5.00 M(+3.8%) |
| Dec 2022 | $4.81 M(-18.1%) | $4.81 M(-8.8%) |
| Sep 2022 | - | $5.28 M(+8.7%) |
| Jun 2022 | - | $4.85 M(-16.6%) |
| Mar 2022 | - | $5.82 M(-0.8%) |
| Dec 2021 | $5.87 M(+70.2%) | $5.87 M(+10.7%) |
| Sep 2021 | - | $5.30 M(-7.3%) |
| Jun 2021 | - | $5.72 M(+1.1%) |
| Mar 2021 | - | $5.66 M(+64.2%) |
| Dec 2020 | $3.45 M(-39.8%) | $3.45 M(-8.9%) |
| Sep 2020 | - | $3.79 M(+3.9%) |
| Jun 2020 | - | $3.64 M(-36.4%) |
| Dec 2019 | $5.73 M(+16.1%) | - |
| Dec 2019 | - | $5.73 M(+22.1%) |
| Sep 2019 | - | $4.70 M(-10.2%) |
| Jun 2019 | - | $5.23 M(+23.1%) |
| Mar 2019 | - | $4.24 M(-14.0%) |
| Dec 2018 | $4.94 M(+89.9%) | - |
| Dec 2018 | - | $4.94 M(+11.2%) |
| Sep 2018 | - | $4.44 M(-0.8%) |
| Jun 2018 | - | $4.47 M(-11.3%) |
| Mar 2018 | - | $5.05 M(+94.1%) |
| Dec 2017 | $2.60 M | - |
| Dec 2017 | - | $2.60 M(-50.9%) |
| Sep 2017 | - | $5.30 M(-15.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $6.23 M(-2.9%) |
| Mar 2017 | - | $6.42 M(+2.0%) |
| Dec 2016 | $6.29 M(-12.1%) | - |
| Dec 2016 | - | $6.29 M(+6.6%) |
| Sep 2016 | - | $5.90 M(-1.7%) |
| Jun 2016 | - | $6.01 M(-15.3%) |
| Mar 2016 | - | $7.09 M(-0.9%) |
| Dec 2015 | $7.16 M(+114.9%) | - |
| Dec 2015 | - | $7.16 M(-11.9%) |
| Sep 2015 | - | $8.12 M(+129.0%) |
| Jun 2015 | - | $3.54 M(-2.8%) |
| Mar 2015 | - | $3.65 M(+9.6%) |
| Dec 2014 | $3.33 M(+53.0%) | - |
| Dec 2014 | - | $3.33 M(+77.6%) |
| Sep 2014 | - | $1.87 M(+5.1%) |
| Jun 2014 | - | $1.78 M(-27.8%) |
| Mar 2014 | - | $2.47 M(+13.5%) |
| Dec 2013 | $2.18 M(-7.1%) | $2.18 M(+48.5%) |
| Sep 2013 | - | $1.47 M(-56.1%) |
| Jun 2013 | - | $3.34 M(-12.2%) |
| Mar 2013 | - | $3.80 M(+62.4%) |
| Dec 2012 | $2.34 M(+45.4%) | - |
| Dec 2012 | - | $2.34 M(+57.5%) |
| Sep 2012 | - | $1.49 M(+10.9%) |
| Jun 2012 | - | $1.34 M(-23.2%) |
| Mar 2012 | - | $1.75 M(+8.5%) |
| Dec 2011 | $1.61 M | - |
| Dec 2011 | - | $1.61 M(+44.2%) |
| Sep 2011 | - | $1.12 M |
FAQ
- What is Can-Fite BioPharma annual total liabilities?
- What is the all time high annual total liabilities for Can-Fite BioPharma?
- What is Can-Fite BioPharma annual total liabilities year-on-year change?
- What is Can-Fite BioPharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Can-Fite BioPharma?
- What is Can-Fite BioPharma quarterly total liabilities year-on-year change?
What is Can-Fite BioPharma annual total liabilities?
The current annual total liabilities of CANF is $3.75 M
What is the all time high annual total liabilities for Can-Fite BioPharma?
Can-Fite BioPharma all-time high annual total liabilities is $7.16 M
What is Can-Fite BioPharma annual total liabilities year-on-year change?
Over the past year, CANF annual total liabilities has changed by -$1.06 M (-22.14%)
What is Can-Fite BioPharma quarterly total liabilities?
The current quarterly total liabilities of CANF is $3.44 M
What is the all time high quarterly total liabilities for Can-Fite BioPharma?
Can-Fite BioPharma all-time high quarterly total liabilities is $8.12 M
What is Can-Fite BioPharma quarterly total liabilities year-on-year change?
Over the past year, CANF quarterly total liabilities has changed by -$715.00 K (-17.20%)